Exane Derivatives’s JD.com JD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$1.06M Buy
16,526
+9,749
+144% +$562K 0.61% 38
2022
Q1
$392K Sell
6,777
-446
-6% -$30.3K 0.11% 217
2021
Q4
$506K Sell
7,223
-3,113
-30% -$246K 0.12% 175
2021
Q3
$747K Buy
10,336
+2,815
+37% +$208K 0.18% 124
2021
Q2
$575K Hold
7,521
0.13% 159
2021
Q1
$634K Sell
7,521
-4,126
-35% -$378K 0.18% 121
2020
Q4
$1.02M Sell
11,647
-4,398
-27% -$367K 0.3% 83
2020
Q3
$1.25M Sell
16,045
-3,034
-16% -$211K 0.36% 59
2020
Q2
$1.15M Sell
19,079
-318
-2% -$16.1K 0.31% 84
2020
Q1
$786K Sell
19,397
-2,114
-10% -$84.5K 0.22% 90
2019
Q4
$855K Buy
21,511
+1,094
+5% +$35.3K 0.16% 107
2019
Q3
$576K Buy
20,417
+13,432
+192% +$406K 0.1% 152
2019
Q2
$211K Buy
6,985
+4,664
+201% +$134K 0.04% 256
2019
Q1
$70K Sell
2,321
-1,279
-36% -$32.5K 0.01% 323
2018
Q4
$75.3K Buy
+3,600
New +$80.5K 0.01% 343

Other funds holding JD

Exane Derivatives's JD Position: Q2 2022 in Review

Exane Derivatives increased its JD.com (JD) stake by 144% in Q2 2022, buying an estimated $562K and bringing the position to 16,526 shares worth $1.06M. The position accounts for 0.61% of the portfolio, ranked #38.

Exane Derivatives first reported a position in JD in Q4 2018 and has held it in 15 quarters since. The position peaked at $1.25M in Q3 2020. 582 funds tracked by Wall St. Rank hold JD as of Q2 2022.

  • Exane Derivatives held 16,526 shares of JD.com worth $1.06M as of Q2 2022.
  • Exane Derivatives bought 9,749 JD.com shares in Q2 2022, an estimated $562K.
  • JD.com made up 0.61% of Exane Derivatives's portfolio in Q2 2022, its #38 holding.
  • Exane Derivatives first reported a position in JD.com in Q4 2018 and has held it in 15 quarters since.
  • Exane Derivatives's JD.com position peaked at $1.25M in Q3 2020.
  • 582 funds tracked by Wall St. Rank held JD.com as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.